Complementary Roles in Cancer Prevention: Protease Inhibitor Makes the Cancer Preventive Peptide Lunasin Bioavailable
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The lower incidence of breast cancer among Asian women compared with Western countries has been partly attributed to soy in the Asian diet, leading to efforts to identify the bioactive components that are responsible. Soy Bowman Birk Inhibitor Concentrate (BBIC) is a known cancer preventive agent now in human clinical trials. METHODOLOGY/PRINCIPAL FINDINGS: The objectives of this work are to establish the presence and delineate the in vitro activity of lunasin and BBI found in BBIC, and study their bioavailability after oral administration to mice and rats. We report that lunasin and BBI are the two main bioactive ingredients of BBIC based on inhibition of foci formation, lunasin being more efficacious than BBI on an equimolar basis. BBI and soy Kunitz Trypsin Inhibitor protect lunasin from in vitro digestion with pancreatin. Oral administration of (3)H-labeled lunasin with lunasin-enriched soy results in 30% of the peptide reaching target tissues in an intact and bioactive form. In a xenograft model of nude mice transplanted with human breast cancer MDA-MB-231 cells, intraperitoneal injections of lunasin, at 20 mg/kg and 4 mg/kg body weight, decrease tumor incidence by 49% and 33%, respectively, compared with the vehicle-treated group. In contrast, injection with BBI at 20 mg/kg body weight shows no effect on tumor incidence. Tumor generation is significantly reduced with the two doses of lunasin, while BBI is ineffective. Lunasin inhibits cell proliferation and induces cell death in the breast tumor sections. CONCLUSIONS/SIGNIFICANCE: We conclude that lunasin is actually the bioactive cancer preventive agent in BBIC, and BBI simply protects lunasin from digestion when soybean and other seed foods are eaten by humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells.
Galvez, A. F., & de Lumen, B. O. (1999) · Nature Biotechnology · doi:10.1038/8676 · Cited by 174 · cited 1×
“Lunasin is a novel peptide initially identified in soybean [5] and subsequently, isolated in wheat, barley and other seeds [6–9].”
Mai, Z., Blackburn, G. L., & Zhou, J.-R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm004 · Cited by 64
Cited by
The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins
Zou, T.-B., He, T.-P., Li, H.-B., Tang, H.-W., & Xia, E.-Q. (2016) · Molecules · doi:10.3390/molecules21010072 · Cited by 879
Bioactive peptides in cereals and legumes: agronomical, biochemical and clinical aspects.
Malaguti, M., Dinelli, G., Leoncini, E., Bregola, V., Bosi, S., Cicero, A., & Hrelia, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121120 · Cited by 180
“[34] demonstrated that BBI could prevent lunasin digestion thanks to its protease inhibitory activity,”
BackgroundBioactive Food Peptides in Health and Disease
(2013) · InTech eBooks · doi:10.5772/3318 · Cited by 168
Clemente, A., Sonnante, G., & Domoney, C. (2011) · Current Protein & Peptide Science · doi:10.2174/138920311796391133 · Cited by 63
“An example of such a protected compound is lunasin, a small soybean peptide with efficacy in mammalian cells against damage by chemical carcinogens and viral oncogenes [122].”
BackgroundFood Peptides for the Nutricosmetic Industry
Dini, I., & Mancusi, A. (2023) · Antioxidants · doi:10.3390/antiox12040788 · Cited by 28
Metadata
- Authors
- Hsieh, C.-C., Hernández-Ledesma, B., Jeong, H. J., Park, J. H., & de Lumen, B. O.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-26
- Volume
- 5
- Issue
- 1
- Pages
- e8890
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1986040852
- Cited by
- 137
- References
- 2
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.